Ability to regulate emotion is predicted by depressive symptoms and cognitive function in a cardiac sample

Journal of Cardiovascular Nursing

Volumn 28, Issue 5, 2013, Pages 453-459

  Spitznagel, Mary Beth ^a   Potter, Vanessa ^b   Miller, Lindsay A ^a   Roberts Miller, Angela N ^a   Hughes, Joel ^a   Rosneck, Jim ^a   Gunstad, John ^a  

^a KENT STATE UNIVERSITY   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

cardiovascular disease; depression; emotion regulation; executive function

Indexed keywords

CARDIOVASCULAR DISEASE; COGNITION; DEPRESSION; EMOTION; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGY; ARTICLE; PSYCHOLOGICAL ASPECT;

CARDIOVASCULAR DISEASES; COGNITION; DEPRESSION; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84883453368     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e318256be99     Document Type: Article

References (39)

1. Gross JJ. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol. 1988;2(3):271-299.
2. Keltner D, Kring AM. Emotion, social function, and psychopathology. Rev Gen Psychol. 1998;2:320-342. (Pubitemid 128608318)
3. Kelly BM, Schwartz D, Gorman AH, Nakamoto J. Violent victimization in the community and children's subsequent peer rejection: the mediating role of emotion dysregulation. J Abnorm Child Psychol. 2008;36:175-185.
4. Gross JJ, Munoz RF. Emotion regulation and mental-health. Clin Psychol. 1995;2(2):151-164.
5. Burton KW, Kaszniak AW. Emotional experience and facial expression in Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006;13(3Y4):636-651.
6. Henry JD, Green MJ, de Lucia A, Restuccia C,McDonald S, O'Donnell M. Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting. Schizophr Res. 2007;95(1Y3):197-204. (Pubitemid 47313642)
7. Teasdale TW, Engberg AW. Psychosocial consequences of stroke: a long-term population-based follow-up. Brian Inj. 2005;19(12):1049-1058. (Pubitemid 41701027)
8. Liverant GI, Brown TA, Barlow DH, Roemer L. Emotion regulation in unipolar depression: the effects of acceptance and suppression of subjective emotional experience on the intensity and duration of sadness and negative affect. Behav Res Ther. 2008;46(11):1201-1209.
9. Hänsel A, von Känel R. The ventro-medial prefrontal cortex: a major link between the autonomic nervous system, regulation of emotion, and stress reactivity? Biopsychosoc Med. 2008;2:21.
10. Jaracz J. The anatomy of depression in light of evidence from neuroimaging studies. Psychiatr Pol. 2008;42(6): 875-888.
11. Mak AK, Wong MM, Han SH, Lee TM. Gray matter reduction associated with emotion regulation in female outpatients with major depressive disorder: a voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(7):1184-1190.
12. Glotzbach E, Mühlberger A, Gschwendtner K, et al. Prefrontal brain activation during emotional processing: a functional near infrared spectroscopy study (fNIRS). Open Neuroimag J. 2011;5:33-39.
13. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20(1): 29-43. (Pubitemid 28109986)
14. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768-1775.
15. Woo MA, Kumar R, Macey PM, Fonarow GC, Harper RM. Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail. 2009;15(3):214-223.
16. Paul RH, Gunstad J, Poppas A, et al. Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease. Cerebrovasc Dis. 2005;20(2):129-133. (Pubitemid 41160213)
17. Lezak MD. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press, 2004.
18. Ardila A. On the evolutionary origins of executive functions. Brain Cogn. 2008;68(1):92-99.
19. Cohen RA, Poppas A, Forman DE, et al. Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol. 2009;31(1):96-110.
20. Beck AT, Steer RA, Brown GK. Beck Depression Inventory. 2nd ed. San Antonio, TX: Psychological Corporation; 1996.
21. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess. 2004;26(1):41-54. (Pubitemid 38182213)
22. Catanzaro SJ, Mearns J. Measuring generalized expectancies for negative mood regulation: initial scale development and implications. J Pers Assess. 1990;54(3&4):546-563. (Pubitemid 20303608)
23. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(8): 271-227.
24. Ruff RM,Niemann H, Allen CC. The Ruff 2 and 7 Selective Attention Test: a neuropsychological application. Percept Mot Skills. 1992;75:1311-1319.
25. Teng EL, Chui HC. The Modified Mini-Mental Sate (3MS) examination. J Clin Psychiatry. 1987;48(8):314-318. (Pubitemid 17138128)
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
27. Bland RC, Newman SC. Mild dementia or cognitive impairment: the Modified Mini-Mental State Examination (3MS) as a screen for dementia. Can J Psychiatry. 2001;46(6): 506-510. (Pubitemid 32861417)
28. Alosco ML, Spitznagel MB, Raz N, et al. The 2-Minute Step Test is independently associated with cognitive function in older adults with heart failure. Aging Clin Exp Res. 2011;19:3-18.
29. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract. 2011;23(11):577-585.
30. Karlsson MR, Edner M, Henriksson P, et al. A nursebased management program in heart failure patients affects females and persons with cognitive dysfunction most. Patient Educ Couns. 2005;58(2):146-153. (Pubitemid 40966060)
31. Van der Wal MH, Jaarsma T, Moser DK, et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434-440. (Pubitemid 43209168)
32. Shishani K, Sohn M, Okada A, Froelicher ES. Nursing interventions in tobacco-dependent patients with cardiovascular diseases. Annu Rev Nurs Res. 2009;27:221-242.
33. Oller-Canet S and Fernández-San Martn MI, Garca-Lecina R et al. Do depressed patients comply with treatments prescribed? A crosssectional study of adherence to the antidepressant treatment. Actas Esp Psiquiatr. 2011;39(5), 288-293.
34. Vinvoles E, de la Figuera M, Gonzalez-Segura D. Cognitive function and blood pressure control in hypertensivesover 60 years of age: COGNIPRES study. Curr Med Res Opin. 2008;24:3331-3339.
35. CrammJM, Nieboer AP. Self-management abilities, physical health and depressive symptoms among patients with cardiovascular diseases, chronic obstructive pulmonary disease, and diabetes [published online ahead of print January 3, 2012]. Patient Educ Couns.
36. O'Neil A, Sanderson K, Oldenburg B, Taylor CB. Impact of depression treatment on mental and physical healthrelated quality of life of cardiac patients: a meta-analysis. J Cardiopulm Rehabil Prev. 2011;31(3):146-156.
37. Cohen RA. Introduction. In Cohen RA, Gunstad J, eds. Neuropsychology and Cardiovascular Disease. New York, NY: Oxford University Press; 2010:3-18.
38. Wolfe R, Worrall-Carter L, Foister K, Keks N, Howe V. Assessment of cognitive function in heart failure patients. Eur J Cardiovasc Nurs. 2006;5(2):158-164. (Pubitemid 44287868)
39. Hofman A, Ott A, Breteler M, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997;49(9046): 151-154. (Pubitemid 27039193)